Aki Nakamura

NO-1886, a lipoprotein lipase activator, attenuates vascular smooth muscle contraction in rat aorta.

Y. Nakaya, N. Harada, K. Mawatari, 2007, European journal of pharmacology.

Identification of cis-acting promoter sequences required for expression of the glycerol-3-phosphate acyltransferase 1 gene in mice.

Haruka Yonemoto, Y. Nakaya, K. Yoshimoto, 2009, Biochimica et biophysica acta.

Activation of lipoprotein lipase increases serum high density lipoprotein 2 cholesterol and enlarges high density lipoprotein 2 particles in rats.

Y. Nakaya, T. Miyata, K. Tsutsumi, 2011, European journal of pharmacology.

NO-1886, a lipoprotein lipase activator, attenuates contraction of rat intestinal ring preparations.

Yinhua, Y. Nakaya, Qinkai Li, 2008, The journal of medical investigation : JMI.

Pioglitazone-induced body weight gain is prevented by combined administration with the lipoprotein lipase activator NO-1886.

Y. Nakaya, T. Miyata, K. Tsutsumi, 2011, European journal of pharmacology.

Insulin Activates ATP-Sensitive Potassium Channels via Phosphatidylinositol 3-Kinase in Cultured Vascular Smooth Muscle Cells

Y. Nakaya, T. Hosaka, N. Harada, 2007, Journal of Vascular Research.

Identification of cis-acting promoter sequences required for expression of the glycerol-3-phosphate acyltransferase 1 gene in mice.

Haruka Yonemoto, Y. Nakaya, K. Yoshimoto, 2009, Biochimica et biophysica acta.